학술논문
Corrigendum to PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study Volume 14, Issue 3, May–June 2020, Pages 322-330.e5
Document Type
Erratum
Author
Source
In Journal of Clinical Lipidology September-October 2020 14(5):741-741
Subject
Language
ISSN
1933-2874